SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Schedule Of Net Sales And Operating Income By Reportable Segment

Net sales and profit by reportable segment for the years ended December 31, 2013, 2012 and 2011 are as follows:

	Years Ended December 31,
	2013			2012			2011
	(In thousands)
Segment Net Sales
U.S. Neurosurgery	$	172,250		$	171,278		$	165,652
U.S. Instruments	159,627			162,323			155,833
U.S. Extremities	134,683			122,847			98,109
U.S. Spine and Other	179,940			190,546			174,479
International	189,714			183,877			186,005
Total revenues	$	836,214		$	830,871		$	780,078
Segment Profit
U.S. Neurosurgery	$	83,211		$	91,070		$	86,206
U.S. Instruments	45,629			46,294			41,883
U.S. Extremities	53,189			49,432			38,540
U.S. Spine and Other	8,546			55,891			51,011
International	56,869			61,336			64,164
Segment profit	247,444			304,023			281,804
Amortization	(12,697)			(18,536)			(16,433)
Corporate and other	(238,391		)	(211,705		)	(210,459		)
Operating income (loss)	$	(3,644	)	$	73,782		$	54,912

Revenues By Market Category

Revenue by major product category consisted of the following:

	Years Ended December 31,
	2013		2012		2011
	(In thousands)
Orthopedics	$	374,640	$	369,312	$	328,933
Neurosurgery	278,672		277,527		272,538
Instruments	182,902		184,032		178,607
Total Revenues	$	836,214	$	830,871	$	780,078

Total Revenue By Major Geographic Area

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

	United States*		Europe		Rest of the World		Consolidated
	(In thousands)
Total revenue, net:
2013	$	642,694	$	93,977	$	99,543	$	836,214
2012	642,830		90,920		97,121		830,871
2011	589,946		97,184		92,948		780,078
Total long-lived assets:
2013	$	187,608	$	20,010	$	1,030	$	208,648
2012	166,508		20,242		1,507		188,257

* Includes long-lived assets in Puerto Rico.